Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Berberine
Cat. No.:
OB0225LY-0408
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Berberine is a broad-spectrum antimicrobial drug with effects on lipid metabolism.
Synonym:
Berberin; Umbellatine; 2086-83-1; Berbericine; Majarine; Thalsine; Umbellatin; Berberone; Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-; 9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium
CAS No.:
2086-83-1
Compound CID:
2353
Formula:
C20H18NO4
Formula Weight:
336.36
Specification
Relative Density:
1.2976 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Berberine can be used to explore its important role in metabolic syndrome and blood glucose regulation.
Library Information
Targets:
Topoisomerase; Reactive oxygen species
Pathways:
Immunology/Inflammation; NF-κB; DNA damage/DNA repair; Autophagy; Metabolism; Microbiology/Virology
Plate Number:
AOCL-6
Plate Location:
c4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
5.63 mg/mL; 16.72 mM
Water Max Solubility:
<1 mg/mL (insoluble)
Solubility:
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.05 mg/mL (6.09 mM), soluble in chloroform, dichloromethane, ethyl acetate, and acetone.
